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Purpose: To review the literature on home blood pressure measurement (HBPM), to examine 
its validity and applicability for clinical practice and to provide recommendations regarding 
HBPM assessment.
Findings: HBPM can eliminate the white coat effect and offers the possibility to obtain 
multiple measurements under standardized conditions, which increases knowledge of overall 
blood pressure value. Although it is not entirely capable of replacing ambulatory blood pressure 
measurement (ABPM), HBPM correlates better with target organ damage and cardiovascular 
mortality than ofﬁ  ce blood pressure measurement (OBPM), it enables prediction of sustained 
hypertension in patients with borderline hypertension, and proves to be an appropriate tool 
for assessing drug efﬁ  cacy. Additional advantages of HBPM are that it may increase drug 
compliance and patient’s awareness of hypertension. Overall, OBPM yield higher blood pres-
sure values than HBPM. Differences between OBPM and HBPM tend to increase with age 
and are generally higher in patients without antihypertensive treatment than in patients with 
antihypertensive treatment.
Recommendations: Measurements should be performed according to accepted guidelines 
and recordings should be performed with a memory equipped automatic validated device. 
From the data reviewed here, we recommend that HBPM be assessed monthly by taking two 
measurements in the morning within 1 hour after awakening and two in the evening for three 
consecutive days, the data from the ﬁ  rst day should be dismissed. A subject should be labeled 
hypertensive if his/her HBPM value is equal to or greater than 137 mmHg systolic and/or 
84 mmHg diastolic.
Keywords: blood pressure, hypertension, self-measurement, home measurement, ambulatory 
measurement, adherence
Introduction
Home blood pressure measurement (HBPM) is an ideal approach to assess someone’s 
usual blood pressure (BP). For this purpose, there are presently several suitable devices 
available which have been rigorously tested. Their performance characteristics can 
easily be retrieved via the internet (http://www.dableducation.org), thus allowing 
deliberate decisions when one wants to purchase one of these. However, current 
guidelines with respect to HBPM differ among advising hypertension societies and 
there is no consensus yet about optimal strategies to be employed. Therefore, the cli-
nician who wants to apply HBPM in practice will still be confronted with a number 
of uncertainties relating to eg, the reproducibility and accuracy of the technique, its 
ability to diagnose hypertension and the clinical implications of the obtained results. 
In a recent systematic review, we addressed in a rather concise way several of these 
items (Verberk et al 2005). The intention of the present review is to elaborate on 
these issues in somewhat greater detail. We have based our analyses on papers that Vascular Health and Risk Management 2007:3(6) 960
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were published in the period 1992–2005 and which were 
retrieved from PUBMED, EMBASE and the Cochrane 
database.
Reproducibility and accuracy 
of home blood pressure 
measurements
The issue of reproducibility was addressed by Celis et al 
(1997), who evaluated in older patients for how many days 
BP had to be measured in order to obtain steady levels of 
HBPM. They had 74 patients (= 60 years) measure their BP 
at home for 10 consecutive days. Sitting BP was measured 
once a day at noon. The average home blood pressure of the 
ﬁ  rst three days was compared with the average of all ten 
days of measurement. No signiﬁ  cant difference was found 
between these two averages, which led the investigators to 
conclude that three days of HBPM are sufﬁ  cient to obtain a 
steady, reproducible level of sitting and standing BP.
Imai et al (1993) supported this conclusion in their study 
on HBPM among 363 households. While a total of 871 
subjects were asked to perform HBPM once in the morning 
within 1h of waking, every day for four weeks, most subjects 
measured their HBP only about 21 times. Although this study 
was not designed to investigate reproducibility of HBPM, a 
preliminary analysis showed that the average home systolic 
BP (mean ± SD) in 458 subjects for the ﬁ  rst three days of 
the 21-day period (123.2 ± 18.4 mmHg) was similar to that 
of the entire period (122.8 ± 17.5 mmHg). There was no 
signiﬁ  cant difference among home diastolic BP throughout 
the 21 days of the study.
Theoretically, the time at which measurements are per-
formed may contribute to the degree of reproducibility of 
HBPM. In this respect, results of the Ohasama-study (Imai 
et al 1999) showed that morning HBPM yielded signiﬁ  -
cantly higher values than evening HBPM, albeit with lesser 
variability. In contrast, the Dübendorf-study (Weisser et al 
1994) found lower BP levels with higher variability in the 
morning as compared to the evening. However, both stud-
ies differed with respect to population and methods. The 
Dübendorf-study excluded all patients who used antihyper-
tensive medication, whereas 27% of the Ohasama population 
received antihypertensive treatment. Furthermore, evening 
HBPM in the Dübendorf-study was performed between 
18.00 and 20.00 hour instead of before going to bed as in 
the Ohasama study.
Stergiou, Skeva et al (1998) have investigated both 
reproducibility and accuracy in the same group of patients. 
A total of 189 patients measured their BP during six working 
days, twice in the morning and twice in the evening. 
Reproducibility of HBPM was determined from the standard 
deviation (SD) of the measurements. Results showed that 
home BP on day 1 was higher than on each of days 2–6, with 
no difference among days 2–6. After comparing HBPM with 
ABPM, data indicated that a minimum program for a reliable 
estimation of HBP is to assess the average of the second and 
third workday, as this led to sufﬁ  cient reduction in SD and a 
good correlation with ABPM data. Consequently, the results 
of the ﬁ  rst day of HBPM should, in general, be discarded.
Most studies on self-registration of BP are based on 
measurements taken at home. However, it is possible that 
BP at home differs from BP at work due to job stress or other 
factors and that BP recorded at work might give a better 
indication of the overall BP value. This issue was addressed 
by Garcia-Vera and Sanz (Garcia-Vera and Sanz 1999) who 
studied BP measurements at work in addition to the number 
of measurements at home needed to estimate overall BP. 
Forty-three treated hypertensive patients self-recorded BP 
for 8-days three times a day (twice at home in the morning 
and evening and once at work at noon), thus collecting a total 
of 24 measurements. This procedure was repeated after one 
and 6-months. Results showed that it is enough to take two 
readings, one at work and the other at home, from 3 consecu-
tive days to get reliable estimates of BP over 1-week and 
over 2-months. However, for reliable results over 6-months 
BP has to be measured for 2 consecutive days longer. Other 
ﬁ  ndings of this study were that the reliability of self-measured 
BP taken at work was consistently, although not signiﬁ  cantly 
higher than that obtained at home. Furthermore, diastolic BP 
needed fewer measurements for a proper estimation than 
systolic BP. Finally, the investigators emphasized that BP 
variability should not be underestimated and since BP vari-
ability increases with age that more self-BP readings should 
be obtained in older patients.
Finally, Brook (2000) performed an analysis among 
12 published studies on HBPM in order to describe the effects 
of home monitoring schedules on the accuracy of BP registra-
tions. Results showed that variations in monitoring schedules 
did not signiﬁ  cantly affect the accuracy of home BP. In fact, 
the correlation between HBPM and ABPM did not improved 
with a greater number of home measurements. This implies 
that the accuracy of HBPM cannot only be explained by the 
large number of measurements, as is so frequently assumed. 
Rather, it suggests that HBPM is intrinsically different from 
OBPM and reﬂ  ects overall BP better.
An important point that has not received much attention 
is whether some of the discrepancies between the various Vascular Health and Risk Management 2007:3(6) 961
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studies regarding reproducibility and accuracy could not be 
explained simply by different devices being used. Unfortu-
nately, there is not enough information about head-to-head 
comparisons of devices for self-measurement within the same 
individuals. Therefore, this possibility remains enigmatic.
When to diagnose hypertension on 
the basis of home measurements?
One of the ﬁ  rst studies to determine reference values for HBPM 
was performed by de Gaudemaris et al (1994) They analyzed 
HBPM and OBPM data from 390 subjects, aged 20–59 
years, who were not on antihypertensive treatment. Three 
HBPMs were performed in the morning and in the evening 
for 3 consecutive days, whereas OBPM was determined by 
3 consecutive measurements at one visit. HBPM in the morn-
ing was lower than in the evening. Furthermore, within each 
session HBPM decreased after each measurement leading to 
the third HBPM being lower than the ﬁ  rst. The same pattern 
was noted for the days of measurements; HBPM at the third 
day was lower than at the ﬁ  rst day. Normal values for HBPM 
were determined by means of the so-called correspondence 
criterion with the upper limit for OBPM according to WHO 
criteria (140/90 and 160/95 mmHg) as reference. Using this 
approach, the upper limit for normotension by HBPM was 
proposed to be 127/83 mmHg. BP levels above 147/86 mmHg 
were considered to represent hypertension.
The Dübendorf study is a large population-based study 
that also set out to obtain normal values for HBPM (Weisser 
et al 1994). A total of 503 randomly selected individuals, 
who did not use antihypertensive drugs, were studied. All 
subjects performed HBPM during 14-days in the morning 
between 6 and 8 am and in the evening between 6 and 8 pm. 
OBPM was done before and after this two-week period. At 
the end, the means of both measurements were compared. 
Mean OBPM data (130.0 ± 16.5/82.1 ± 11.1 mmHg) were 
signiﬁ  cantly higher than mean HBPM data (123.1 ± 14.6/ 
77.6 ± 10.7 mmHg). When one takes an ofﬁ  ce pressure of 
140 mmHg systolic and 90 mmHg diastolic as the upper 
limit of normal, these values reﬂ  ected the 76.3% percentile 
(systolic) and 78.4 percentile (diastolic) of the distribution 
from the Dübendorf population. Corresponding HBPM 
values at these percentiles were 133 mmHg systolic and 
86 mmHg diastolic, which were therefore set as the upper 
limits for normality. It would have been incorrect to use the 
difference between average HBPM and average OBPM as 
a correction factor since differences between HBPM and 
OBPM are greater in hypertensives than in normotensives 
(Battig et al 1989). Since the WHO/ISH had classiﬁ  ed an 
OBPM of 120/80 mmHg as optimal and 130/85 mmHg as 
the limit between normal and high-normal BP (Guidelines 
Subcommittee 1999), the investigators from the Dübendorf 
study proposed to set the corresponding HBPM values at 
115/75 and 125/80 respectively (Weisser et al 2000).
The Didima study which is comparable to the Dübendorf 
study analyzed 562 untreated subjects of an average popula-
tion (Stergiou et al 2000). OBPM was taken on two visits 
(triplicate measurements) and HBPM was performed on 3 
workdays (duplicate morning and evening measurements). 
HBPM thresholds for hypertension were determined accord-
ing to three different approaches: (1) as 139.7/83.0 mmHg, 
using the percentile criterion (95th percentile of the HBPM 
distribution among 476 normotensive subjects), (2) as 
139.7/85.8 mmHg, using the correspondence criterion (the 
percentiles of the HBPM distribution that correspond to 
OBPM values = 140/90 mmHg) and (3) as 137.4/82.7 mmHg 
using the regression equation between HBPM and OBPM 
data (calculation of that HBPM value which corresponds to 
an OBPM of 140/90 using the regression equation between 
HBPM and OBPM). These results led the investigators to 
suggest that an average HBPM below 137/82 mmHg might 
be regarded as normal, and one above 140/86 mmHg as prob-
ably abnormal. Pressures between these limits would then 
have to be considered as borderline. This study eliminated 
the results of the ﬁ  rst day measurements for both OBPM and 
HBPM and this resulted in better correlations between the 
two types of measurements.
The Pamela study analyzed data from a random sample 
of 1438 subjects who received no antihypertensive drug 
treatment (Mancia et al 2001). HBPM, assessed once in the 
evening on the day of the medical visit and once the follow-
ing morning, was compared to OBPM, which was assessed 
on one medical visit for three consecutive times. OBPM 
yielded markedly higher blood pressure values than HBPM. 
Results led the investigators to propose normal values of 
132/83 mmHg on the basis of the 95th percentile method 
(Mancia et al 2001) and to 130/81 mmHg on the basis of the 
regression equation method (Mancia et al 1995).
Because so many studies have compared OBPM with 
HBPM, Thijs et al (1998) performed a meta-analysis in an 
attempt to determine an operational threshold for HBPM. 
Seventeen studies were analyzed containing a total of 
5422 subjects. Comparison between these studies was 
complicated by differences in type of subjects (age, nor-
motensive-hypertensive and untreated-treated), differences 
in devices (oscillometric-auscultatory) and differences in 
measurement procedures. With weighting for the number of Vascular Health and Risk Management 2007:3(6) 962
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subjects included in the various studies the average HBPM 
data were 115/71 mmHg in normotensive subjects and 
119/74 mmHg in untreated persons who were not selected 
on the basis of their BP. Different approaches to establish 
normality resulted in four different reference values namely: 
137/89 mmHg and 135/86 mmHg when the mean plus two 
standard deviations or the 95th percentile were taken as 
cut-off points, 125/79 mmHg when the regression between 
OBPM and HBPM was determined and 129/84 mmHg when 
the HBPM value was calculated which corresponded with an 
OBPM of 140/90 mmHg. The same investigators have also 
set up an international database in which a large amount of 
HBPM values were collected obtained from several studies 
on HBPM (Thijs et al 1999). Reference values for HBPM 
from this database were determined according to the 95th 
percentiles of 2401 normotensive subjects, which led to the 
following values: 136/85 mmHg for morning HBPM, 139/86 
for evening readings and 137/85 for all readings.
Probably, the best method to determine optimal or normal 
HBPM values is the one which is based on long-term follow-
up in conjunction with the registration of hypertension-related 
complications. This method has been applied by Tsuji et al 
(1997) in the Ohasama study. Survival data from 1913 sub-
jects (normotensives and hypertensives) aged above 40-years 
who were followed for a mean duration of 5.0-years were 
available for their analysis. During a 4-week period HBPM 
was measured every morning, within 1h after awakening, 
in the sitting position after more than 2 minutes of rest. The 
investigators found a linear association between home sys-
tolic pressure and mortality. The correlation between home 
diastolic pressure and mortality was non-linear and best 
approximated by a second order equation (U-shaped curve). 
With a Cox proportional hazards regression model adjusted 
for age, gender and the use of antihypertensive medication 
the investigators examined the association between baseline 
BP values and overall mortality. Based on the results of this 
analysis, a HBPM value of 137/84 mmHg or above was 
proposed to denote hypertension. Normotension was deﬁ  ned 
as a HBPM level below 137 mmHg systolic and between 
66 and 83 mmHg diastolic. This study, however, has several 
limitations. First of all, the effects of known risk factors for 
cardiovascular diseases such as smoking or cholesterol were 
ignored in the analysis. Second, HBPM were obtained only 
at baseline, and changes in HBPM since then were not taken 
into account. Finally, the mortality from cerebrovascular 
disease in this community was signiﬁ  cantly higher than in 
the overall Japanese population. Another point of discussion 
is the arbitrary endpoint that was used. In the analysis the 
HBPM level with the lowest mortality risk was treated as 
the reference category, which in this case was 75 mmHg for 
home diastolic pressure. It was argued that a 10% increase in 
mortality in comparison to the reference category should be 
considered as a serious and substantial risk. This arbitrarily 
set target value ﬁ  nally let to the proposed normal values. 
However, it remains a critical point of discussion whether a 
10% increase in mortality is an acceptable target or not.
Clinical signiﬁ  cance of home 
measurements
In a recent meta-analysis, Cappuccio et al (2004) showed that 
ofﬁ  ce blood pressure was lower by an average of 4.2 mmHg 
systolic and 2.4 mmHg diastolic in subjects with hypertension 
who had home blood pressure monitoring than in those who 
had standard blood pressure monitoring in the healthcare 
system (Cappuccio et al 2004). The authors also concluded 
that subjects were more likely to achieve target BP values 
when performing HBPM than when performing OBPM. 
This study, therefore, underscores the clinical importance 
of HBPM. As indicated below, HBPM can be useful in a 
number of circumstances.
White coat effect and white coat 
hypertension
White coat hypertension (WCH) refers to the phenomenon 
that clinic blood pressure is elevated while out-of-ofﬁ  ce blood 
pressure is normal. The white coat effect (WCE), on the 
other hand, refers to an increase of blood pressure occurring 
at the time of a clinic visit and dissipating soon thereafter 
(Pickering, Gerin et al 2002). Commonly, the WCE is not 
considered to be a risk factor for stroke and other cardio-
vascular events. However, results from the Ohasama-study 
showed that WCH is not completely innocent as subjects 
with this condition had an approximately 2-fold higher 
risk of eventually developing hypertension as compared to 
sustained normotensives (Ugajin et al 2005). This ﬁ  nding 
was conﬁ  rmed by the results of the PAMELA study, which 
showed a progressive increase in both cardiovascular and 
all-cause mortality risk from subjects in whom ofﬁ  ce, home, 
and ambulatory BP were all normal to those in whom one 
of the three BPs were elevated, regardless of which BP was 
considered (Mancia et al 2006).The WCE is also frequently 
seen and many studies have addressed its determinants. 
The WCE is more prevalent in women than in men (Tsai 
2003), occurs more frequently in normotensives than in 
hypertensives (Zakopoulos et al 2002), it increases with age 
(Mansoor et al 1996) and is more related to untreated than to Vascular Health and Risk Management 2007:3(6) 963
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treated hypertension (Stergiou et al 2004). Since HBPM can 
detect the WCE (Stergiou, Zourbaki et al 1998), it seems to 
be of particular help when dealing with patients with white 
coat hypertension.
Masked hypertension
Another condition in which HBPM may be useful is 
masked hypertension, which is characterized by a normal 
ofﬁ  ce pressure but an elevated pressure outside the ofﬁ  ce 
(Pickering, Davidson et al 2002). This abnormality is not 
readily detected as individuals will usually be classiﬁ  ed as 
being normotensive or, in the case of treated hypertension, 
as being well-controlled. The prevalence of masked 
hypertension varies among series but there is little doubt 
that it is associated with increased cardiovascular morbidity 
and mortality (Ohkubo et al 1998; Bobrie et al 2001, 2004; 
Bjorklund et al 2003; Ohkubo et al 2005).
HBPM and target organ damage
Tsunoda and coworkers have performed a cross-sectional 
study with a ﬁ  ve year follow-up period and which showed 
that HBPM data correlate better with target organ damage 
(TOD), in particular left ventricular mass index (LVMI), 
than OBPM data (Tsunoda et al 2002). This ﬁ  nding was 
conﬁ  rmed by Mule et al (2002) who demonstrated that 
HBPM data, especially those obtained on the second day, 
correlated significantly, and more strongly with LVMI, 
albumin excretion rate and global TOD, including cardiac, 
renal and retinal abnormalities than OBPM data. Since these 
early observations, the results of several other prognostic 
studies have been published which are all consistent with 
the previous ones.
Despite these ﬁ  ndings, it would be wrong to conclude 
that HBPM is always superior to OBPM since Jula et al 
(1999) found that if OBPM data were obtained by a non-
physician these values correlated as well with TOD (LVMI 
and albuminuria) as HBPM and ABPM did. In addition, 
Cuspidi et al (2002) showed that hypertensive patients who 
were well controlled on the basis of HBPM or ABPM but 
who had incomplete OBPM control, have more pronounced 
cardiac alterations than patients in whom both HBPM and 
OBPM values were controlled well. Nevertheless, we can 
safely conclude that HBPM is a valuable predictor of TOD 
and a useful diagnostic modality in clinical practice.
HBPM and cardiovascular mortality
Another way to determine the clinical signiﬁ  cance of HBPM 
is to study the relation between HBPM and cardiovascular 
mortality by means of a prognostic cohort study as has been 
done by Ohkubo et al (1998) in the Ohasama-study. After a 
mean follow-up period of 6.6-years the investigators found 
that HBPM correlated better with cardiovascular mortality 
than OBPM. This ﬁ  nding was conﬁ  rmed by Bobrie et al 
(2004) who concluded that HBPM has better prognostic 
accuracy than OBPM with respect to cardiovascular mor-
tality and cardiovascular events in elderly patients who are 
being treated for their hypertension by general practitioners. 
Fagard et al (2005) studied the prognostic signiﬁ  cance of out-
of-ofﬁ  ce BP among 391 elderly patients in general practice. 
They found that the prognostic value of home BP with regard 
to major cardiovascular events was better than that of ofﬁ  ce 
BP and was at least similar to that of daytime ambulatory 
BP. Finally, the PAMELA study provided evidence for the 
prognostic signiﬁ  cance of HBPM (Mancia et al 2006).
A question which still needs some attention is which 
blood pressure value as obtained with HBPM correlates 
best with outcome. According to the Ohasama study this 
may be already the very ﬁ  rst measurement. Despite some 
discrepancies in the results with regard to morning and 
evening HBPM, it would appear that also the early morning 
surge has prognostic potential, independently from the 24 h 
ambulatory blood pressure proﬁ  le (Kario et al 2003). For 
that reason, HBPM in the morning is probably more valuable 
as compared to evening HBPM in terms of cardiovascular 
prognosis and should, therefore, never be omitted.
HBPM as a guide to treatment
of hypertensive patients
Ambulatory blood pressure monitoring (ABPM) is an appro-
priate tool for the determination of the pharmacodynamic 
properties of antihypertensive drugs, such as onset and dura-
tion of action as well as modiﬁ  cation of the diurnal blood 
pressure proﬁ  le. The capability of ABPM to determine such 
properties seems to be related mainly to the fact that many 
measurements can be obtained under standardized conditions 
and that observer bias can be excluded. Since these charac-
teristics can also be ascribed to HBPM, this technique may 
be a potential substitute for ABPM in monitoring the effects 
of antihypertensive drugs in individual patients as well as in 
groups of patients.
How to determine drug efﬁ  cacy
Since excessive BP variability may be a risk factor for TOD, 
it is important for an antihypertensive drug not only to 
decrease overall BP but also to decrease BP variability and 
to create a smooth BP. The smoothness of antihypertensive Vascular Health and Risk Management 2007:3(6) 964
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drugs can be expressed by means of the trough-to-peak ratio 
(TPR). This is deﬁ  ned as the ratio between an antihyperten-
sive agent’s effect at the end of the interval between doses 
(trough), and its effect at the time of its presumed maximum 
effect a few hours after dosing (peak). ABPM can perform 
about 80 measurements per day and may, therefore, deter-
mine the TPR rather precisely. Since it is impossible to obtain 
so many measurements with HBPM, the morning-to-evening 
ratio (MER) has been introduced as a replacement for TPR 
(Menard et al 1994). For MER one assumes that if medica-
tion is taken with a 24 h-interval, the trough is reached just 
before the new medication is taken after 24 h in the morning 
(M), while 12 h earlier in the evening (E), the full effect of 
the drug can be expected (the peak).
Several studies have already analyzed drug treatment 
using HBPM. In most cases, BP differences before and after 
treatment proved to be greater for OBPM than for HBPM. 
These differences might be ascribed to the expectation of the 
physician who assumes a decline in BP after drug administra-
tion (Vaur et al 1998; Leeman et al 2000). Since a placebo 
effect is not readily apparent with home measurements, 
HBPM seems to be a reliable tool for drug efﬁ  cacy assess-
ment, a ﬁ  nding which more studies conﬁ  rmed (Zannad et al 
1996; Fernandez-Gonzalez et al 2000; Stergiou et al 2002). 
Nevertheless, HBPM has some limitations in comparison to 
ABPM. The latter can measure BP on predetermined times 
without any manipulation by the patient, record BP during 
daily routine, determine nocturnal BP and ascertain whether 
a drug is effective during the early morning surge. It is, 
indeed, important to analyze the effect of antihypertensive 
drugs on the early morning rise since this is associated with 
an increased frequency of cardiovascular events. However, 
since HBPM is less expensive and less inconvenient for the 
patient it still serves as a reliable substitute for ABPM when 
assessing drug effects. Besides, there is already an HBPM 
device available which is able to measure BP during sleep at 
predetermined times (Chonan et al 2001). This HBPM device 
allows measurement of nocturnal BP during more nights at 
different sleep qualities.
Institution of antihypertensive treatment 
according to HBPM
In the THOP trial, Staessen et al investigated whether 
antihypertensive treatment can be instituted on the basis of 
HBPM values (Staessen et al 2004). This randomized clinical 
trial with a duration of 1-year compared OBPM with HBPM 
for their potential to serve as a guide to initiate and titrate 
antihypertensive drug treatment. A total of 400 patients were 
randomized to groups in which antihypertensive treatment 
was based either on HBPM or OBPM. Triplicate morning and 
evening measurements were performed for a 7-day period 
prior to the visit at the physicians’ ofﬁ  ce where OBPM was 
performed. Antihypertensive drug treatment was titrated in a 
stepwise fashion based on either the mean diastolic pressure 
of the 42 HBPMs or the average of the 3 consecutive OBPMs. 
Adjustment of antihypertensive treatment based on HBPM 
led to less intensive drug treatment and lower costs but also 
to less BP control, with no difference in general well-being 
or left ventricular mass. Furthermore, HBPM allowed iden-
tiﬁ  cation of patients with white coat hypertension (WCH). 
These ﬁ  ndings support a strategy to implement HBPM as a 
complementary tool to conventional OBPM. The fact that 
HBPM-based treatment led to less BP control as compared 
to OBPM can be explained by the high threshold (diastolic 
pressure 89 mmHg) on which treatment decisions were 
based. This underscores the need for other prospective out-
come studies to establish which values of HBPM should be 
considered normal.
Adherence to treatment
HBPM may have a positive effect on adherence to treatment 
as it can increase patient’s awareness of hypertension. Vetter 
et al (2000) compared two groups of 622 patients with mild 
to moderate hypertension to test this hypothesis. All patients 
received losartan (50 mg) as monotherapy. Patients were ran-
domized to a group receiving a device (OMRON) to measure 
their pressure at home or to a group where this device was 
not provided. In the group of patients who measured their 
BP at home there was a slight improvement in BP control 
as compared to the patients who did not measure their own 
BP at home.
Ashida et al (2000) investigated the relationship between 
HBPM and compliance with treatment among 1452 patients. 
Patients were asked whether they had a BP monitoring 
device at home or not and how many measurements they 
performed if they possessed one. From these questions it 
could be concluded that patient’s compliance improved with 
increasing HBPM assessments. Additionally, patients who 
measured their BP at home showed more awareness about 
their hypertension as compared to patients who did not. 
However, this study may be biased because patients who 
buy and use a BP monitoring device are likely to be different 
from those who do not.
Marquez-Contreras et al (2006) investigated the 
relationship between HBPM and adherence to treatment 
among 250 patients with newly diagnosed or uncontrolled Vascular Health and Risk Management 2007:3(6) 965
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hypertension. Patients were randomized into two groups: 
one which received standard health care intervention and 
another in which patients received an automatic device for 
performing BP measurements at home. Results at the end 
of the trial showed that patients who performed home mea-
surements had a signiﬁ  cantly better adherence and a greater 
reduction of diastolic BP.
Limitations
Besides the many advantages, HBPM also carries some 
limitations. As is the case with OBPM, several factors can 
disturb HBPM, such as body and arm position, but also 
dinner, alcohol, exercise and smoking. Another source of 
variation of HBPM in both clinical trials and clinical prac-
tice is that the measurements often are not well performed. 
For example, the SMART study lost 35% of their data due 
to bad HBPM performance (Zannad et al 1996). This sub-
stantial loss of recordings was largely related to insufﬁ  cient 
preparation. For all these reasons, patients should receive 
extensive instructions from a well-trained technician to 
ensure that measurements are meticulously performed. Since 
many healthcare practitioners do not use the recommended 
BP measurement technique, attention should also be paid 
to their training. In addition, calibration of the devices used 
should be performed regularly.
Reporting bias
The accuracy of HBPM devices has greatly improved so that 
a validated HBPM device can hardly be considered a cause 
for bad HBPM performance. Reporting bias, however, can 
still be a cause of misinterpretation as was highlighted by 
Johnson et al (1999), who performed a trial in which HBPM 
values, as collected by the patient, had to be reported to the 
physician. Subjects were unaware that their monitor elec-
tronically stored the BP data. Results of this study showed 
that most HBPM results were correctly reported, but that 
erroneous reporting occurred signiﬁ  cantly more often in 
cases of uncontrolled than in well-controlled BP. Therefore, 
to prevent misinterpretation of HBPM one should preferably 
use printer or memory-equipped HBPM devices.
Conclusion
Home blood pressure measurements can already be applied in 
clinical practice if recordings will be taken with an automatic 
validated device. Relatively few studies have attempted to 
determine normal values for HBPM but such values should 
preferably be established on the basis of prognostic studies. 
Although further research is necessary with respect to HBPM 
and its correlation to cardiovascular and cerebrovascular 
disease, there are already enough arguments for implement-
ing HBPM into daily clinical practice. Indeed, HBPM can 
eliminate WCE and offers the possibility to obtain multiple 
measurements under standardized conditions, which may 
lead to reliable BP values with little variability. The tech-
nique may be particularly useful in situations where more 
detailed knowledge of a patient’s daytime BP is required or 
desired such as in borderline hypertension, diabetes mellitus, 
pregnancy and when assessing drug efﬁ  cacy. An additional 
advantage of HBPM is that it may increase compliance with 
treatment and patient’s awareness of hypertension.
However, since HBPM is also subject to reporting bias 
and incorrect performance OBPM should not yet be aban-
doned. Due to an increasing workload for physicians in 
western countries it seems to be only a matter of time before 
people measure their BP at home and transmit it through the 
Internet to the hospital, instead of visiting the doctor at the 
clinic. The feasibility of this modern approach of hyperten-
sion management is currently under investigation.
Note
Supported by grant 945-01-043 from ZONMW (Den 
Haag).
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